Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Deltagen (United States) | Researchclopedia

Back to institutions

Deltagen (United States)

San Mateo, Californiacompany

78

Works

14,163

Citations

62

h-index

Top Research Topics

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Top Researchers

William Novotny

176 works30,578 citationsh-index: 44

Recent Research

IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13

Scott Raskin,Changlin Yang,et al.

20250 citations

Computational Drug Discovery Methods

Wnt/β-catenin signaling in development and cancer

Receptor Mechanisms and Signaling

Drug Transport and Resistance Mechanisms

RNA Interference and Gene Delivery

Chemical Synthesis and Analysis

Statistical Methods in Clinical Trials

Immune cells in cancer

Genetic Mapping and Diversity in Plants and Animals

John J. Eppig Jackson Laboratory

254 works27,969 citationsh-index: 90

Kenneth K. Wu Illinois College

349 works23,750 citationsh-index: 79

Barbara B. Knowles Scripps Research Institute

254 works22,557 citationsh-index: 72

Mark W. Moore University of New England

161 works19,529 citationsh-index: 51

57 works18,415 citationsh-index: 28

PCR221 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Ying Cheng,Tai Qin,et al.

20250 citations

1449P Recurrent patient-reported outcome (PRO)-based symptomatic deterioration predicts progression-free survival (PFS): Results from RATIONALE-305

M. Moehler,Daniel Serrano,et al.

20240 citations

1213P Neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS vs. neoadjuvant placebo (PBO) plus CT with adjuvant PBO in resectable non-small cell lung cancer (NSCLC): patient-reported outcomes (PRO) in the RATIONALE-315 trial

F. Cappuzzo,C. Wang,et al.

20240 citations

CLL-534 Real-World Treatment Switching and Sequencing to Next Line of Therapy of Zanubrutinib, Acalabrutinib, and Ibrutinib in Chronic/Small Lymphocytic Leukemia (CLL/SLL)

Javier Pinilla‐Ibarz,Mei Xue,et al.

20240 citations

Clinical and Financial Burden of Mental Health (MH) Conditions in Patients With Low-Grade Non-Hodgkin Lymphoma (LG-NHL)

Keri Yang,Kaitlyn Esselman,et al.

20240 citations